India Pesticides Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/sahf0esol7ue8ftzhoq55izo.pdf

Key Takeaways


Shalvis Facility: The Growth Engine

D.K. Jain: "We will be putting up 2 to 3 blocks every year for the coming 3 to 4 years. We can accommodate around 10 blocks there easily. And what we feel that at the end of 5 years, we should be able to achieve a revenue of about INR1,000 crores."

CDMO Pipeline & New Registrations

D.K. Jain: "With our Japanese friend, they will be visiting us in the first week of March again. And we are quite hopeful that it will get materialized."

Financial Performance & Mix


Capacity, Capex & Backward Integration

D.K. Jain: "Our objective is not short-term pricing advantage, but long-term cost competitiveness against global manufacturers."

Long-Term Roadmap & Investor Engagement

D.K. Jain: "We will make some more efforts on this, sir. We will contact our IR, and we will ask them to have more investor meetings. And as you rightly said that maybe some research reports could be published, we will have an internal meeting, and we will certainly work on this."

Guidance & Commitments

CommitmentSpecificsTimeline
Shalvis revenue contribution₹80–100 crores from first two blocksFY27
Shalvis second blockReady for productionAugust/September 2026
Shalvis long-term revenueApproximately ₹1,000 croresEnd of 5 years
Total company revenue target₹3,000 crores (Hamirpur ~₹1,000–1,100 cr, existing technical ~₹1,500 cr, B2C ~₹500 cr)By March 2031
FY27 revenue growthApproximately 20% over FY26FY27
FY27 capex₹80–100 crores (Shalvis) + ₹25–30 crores (Sandila)FY27
Sandila capex plan finalizationExact component to be worked out and Board approval soughtBy March 2026
New registration revenueAt least ₹10–15 crores from Australia and New Zealand registrationsNot specified
Future registrationsAt least 7–8 registrations abroadNext year
Fungicide technical productApproximately ₹50 crores revenue contributionNot specified
EBITDA margin range18% to 20%Ongoing
Government incentive at ShalvisPercentage of plant and machinery, spread over 10 yearsAccrues after first phase completion

Key Metrics

MetricQ3 FY26
Total revenue₹229 cr, +31% YoY
EBITDA₹41 cr, +39.7% YoY
EBITDA margin18%, up from 17% in Q3 FY25
Net profit₹23 cr, +41% YoY
PAT margin10%
9M FY26 total revenue₹808 cr, +28% YoY
9M FY26 net profit₹89 cr, +44% YoY
Export revenue₹96 cr, +28% YoY; 42% of total revenue
Domestic revenue₹130 cr, 58% of total revenue
Technical and API share of revenue mix73%, formulations 27%
Capacity utilization65% for Q3
PEDA and Pretilachlor combined revenue₹50 cr to ₹60 cr in Q3
B2C share of total turnover18% to 20%
FY27 revenue growth guidance~20% over FY26
FY27 EBITDA margin guidance18% to 20%